A clinical study comparing oral formulations containing 7.5 % calcium sodium phosphosilicate (NovaMin), 5 % potassium nitrate, and 0.4 % stannous fluoride for the management of dentin hypersensitivity - Sharma, N; Roy, S; Kakar, A (J Clin Dent, 2010)